Biotech, Pharmas ...
Follow
Find
10.0K views | +10 today
Biotech, Pharmas and ideas
A Think Tank for Biotech
Curated by Herve Ansanay
Your new post is loading...
Your new post is loading...
Scooped by Herve Ansanay
Scoop.it!

Nanomédecine : des traitements ciblés grâce aux nanoparticules

Nanomédecine : des traitements ciblés grâce aux nanoparticules | Biotech, Pharmas and ideas | Scoop.it
Agir de façon purement physique sur le corps au moyen de nano-agents : une piste radicalement nouvelle pour affranchir la médecine de la complexité biochimique.
more...
No comment yet.
Scooped by Herve Ansanay
Scoop.it!

Immune system surprise hints at new strategy for fighting HIV - R & D Magazine

The discovery of the innate immunity system’s role in mobilizing the body’s defenses against invading microorganisms has been long studied at Yale Univ.
more...
No comment yet.
Scooped by Herve Ansanay
Scoop.it!

Big Pharma has improved access to meds since 2012 but marketing practices ... - In-PharmaTechnologist.com

Big Pharma has improved access to meds since 2012 but marketing practices ... - In-PharmaTechnologist.com | Biotech, Pharmas and ideas | Scoop.it
Ongoing concerns about marketing practices have taken the shine of a report suggesting Big Pharma efforts have improved parients' access to drugs in developing countries over the past two years.
more...
No comment yet.
Scooped by Herve Ansanay
Scoop.it!

Fluorescent nanoprobe could become a universal, noninvasive method to identify and monitor tumors

Researchers have developed a hybrid metal-polymer nanoparticle that lights up in the acidic environment surrounding tumor cells.
more...
No comment yet.
Scooped by Herve Ansanay
Scoop.it!

In landmark study of cell therapy for heart attack, more cells make a difference

In landmark study of cell therapy for heart attack, more cells make a difference | Biotech, Pharmas and ideas | Scoop.it
Patients who receive more cells get significant benefits. That's a key lesson emerging from a clinical trial that was reported this week at the American Heart Association meeting in Chicago.
more...
No comment yet.
Scooped by Herve Ansanay
Scoop.it!

Personalized cancer drugmaker Blueprint Medicines rakes in $50M Series C

Personalized cancer drugmaker Blueprint Medicines rakes in $50M Series C | Biotech, Pharmas and ideas | Scoop.it
Blueprint Medicines recently announced $50 million Series C round, meant to advance its two lead candidates through clinical trials in 2015 and fund the company's proprietary kinase discovery platform and pipeline.
more...
No comment yet.
Scooped by Herve Ansanay
Scoop.it!

Innovation : BIOTECH FINANCES et NEOMED lancent blog.neomed.ca !

Innovation : BIOTECH FINANCES et NEOMED lancent blog.neomed.ca ! | Biotech, Pharmas and ideas | Scoop.it
Montréal et Lyon, le 20 novembre 2014 – NÉOMED et Biotech Finances conjuguent leurs expertises pour lancer BLOG.NEOMED.CA, un Ecosysblog® 100 % audio dont la vocation est de couvrir en français et en anglais l’actualité des acteurs de tous l
more...
No comment yet.
Scooped by Herve Ansanay
Scoop.it!

Ipsen and CNRS Create the "Archi-Pex" Joint Research and Innovation Lab, in Collaboration with the University of Rennes 1 and CEA - Business Wire (press release)

Ipsen and CNRS Create the "Archi-Pex" Joint Research and Innovation Lab, in Collaboration with the University of Rennes 1 and CEA - Business Wire (press release) | Biotech, Pharmas and ideas | Scoop.it

The aim is to accelerate the development of new formulations of drugs based on self-assembly of peptides.

more...
No comment yet.
Scooped by Herve Ansanay
Scoop.it!

Pionnier des biotechnologies, l'américain Genzyme a réussi à tenir ses promesses

Pionnier des biotechnologies, l'américain Genzyme a réussi à tenir ses promesses | Biotech, Pharmas and ideas | Scoop.it
Les grands traitements du spécialiste des maladies rares ont pour l’instant atteint leurs objectifs.
more...
No comment yet.
Scooped by Herve Ansanay
Scoop.it!

DISPOSITIF MÉDICAL: Plus le handicap est sévère, plus la partie restant à charge est élevée – CISS

DISPOSITIF MÉDICAL: Plus le handicap est sévère, plus la partie restant à charge est élevée – CISS | Biotech, Pharmas and ideas | Scoop.it
Pansements, compresses, orthèses ou stents, bandelettes de lecteurs de glycémie, les dispositifs médicaux sont souvent indispensables en complément d’un suivi ou d’un traitement pour de bons résultats de santé.
more...
No comment yet.
Scooped by Herve Ansanay
Scoop.it!

'Jekyll and Hyde' molecule is key to new personalised medicine for prostate cancer

Researchers who have uncovered the 'monstrous' hidden nature of a molecule involved in prostate cancer say the findings could herald a new form of personalised medicine for patients, with doctors able to use the same molecular target for diagnosis...
more...
No comment yet.
Scooped by Herve Ansanay
Scoop.it!

Drug Spending to Reach $1.3 Trillion by 2018, Report Forecasts

Drug Spending to Reach $1.3 Trillion by 2018, Report Forecasts | Biotech, Pharmas and ideas | Scoop.it

Spending on medicines will rise 30% over the next five years, ballooning to $1.3 trillion in 2018, as about 200 new drugs come to market, patent-cliff expirations ebb, and demand grows worldwide—especially for newer specialty treatments in cancer and hepatitis C, a report by the IMS Institute for Healthcare Informatics has concluded.

more...
No comment yet.
Scooped by Herve Ansanay
Scoop.it!

Atlanta eyes startups for starring role in neuroscience

Atlanta eyes startups for starring role in neuroscience | Biotech, Pharmas and ideas | Scoop.it
NeuroLaunch, the first and only accelerator program in the world specifically for neuroscience technology startups, is helping drive Atlanta's emergence as a neuro-technology hub.
more...
No comment yet.
Scooped by Herve Ansanay
Scoop.it!

Computer model sets new precedent in drug discovery - R & D Magazine

Computer model sets new precedent in drug discovery - R & D Magazine | Biotech, Pharmas and ideas | Scoop.it
A major challenge faced by the pharmaceutical industry has been how to rationally design and select protein molecules to create effective biologic drug therapies while reducing unintended side effects—a challenge that has largely been addressed...
more...
No comment yet.
Scooped by Herve Ansanay
Scoop.it!

Body's bacteria may keep our brains healthy

Body's bacteria may keep our brains healthy | Biotech, Pharmas and ideas | Scoop.it
Study suggests microbes help build the blood-brain barrier that keeps pathogens out
more...
No comment yet.
Scooped by Herve Ansanay
Scoop.it!

Obésité : 30 % de la population mondiale touchée

Obésité : 30 % de la population mondiale touchée | Biotech, Pharmas and ideas | Scoop.it
Longtemps cantonnée aux pays développés, l'épidémie de surpoids et d'obésité touche désormais 2,1 milliards de personnes. Et d'ici 2030, c'est la moitié de la population mondiale qui...
more...
No comment yet.
Scooped by Herve Ansanay
Scoop.it!

3D printed microrobots could be used as drug delivery vessels, and more

3D printed microrobots could be used as drug delivery vessels, and more | Biotech, Pharmas and ideas | Scoop.it
Here’s another tech to file in the “boundless possibility of 3D printing” category: Two Swiss engineering professors are developing microscopic robots that will work inside the body to transport cargo – namely, drugs.
more...
No comment yet.
Scooped by Herve Ansanay
Scoop.it!

Investors Are Backing A Recruiting Revolution

Investors Are Backing A Recruiting Revolution | Biotech, Pharmas and ideas | Scoop.it
Hiring is going high tech thanks to a crop of new venture investments.
more...
No comment yet.
Scooped by Herve Ansanay
Scoop.it!

Pharma deals during October 2014 - PMLiVE

Pharma deals during October 2014 - PMLiVE | Biotech, Pharmas and ideas | Scoop.it

Following on from last month's initiatives from the US Treasury to modify the tax guidelines, there has been a distinct change in the deal flow. One of the big acquisition stories of 2014 has reached closure now that AbbVie is drawing a line under its planned acquisition of Shire and other companies are backing off or restructuring planned M&A.

more...
No comment yet.
Scooped by Herve Ansanay
Scoop.it!

Global medicines spend to reach $1.3trn by 2018 - PMLiVE

Global medicines spend to reach $1.3trn by 2018 - PMLiVE | Biotech, Pharmas and ideas | Scoop.it

It seems pharma has finally overcome the dreaded 'patent cliff' with a new report suggesting that global medicines spend will grow by $305-335bn for the five year period to the end of 2018.

more...
No comment yet.
Scooped by Herve Ansanay
Scoop.it!

The U.K. is open for biotech business, and Merck is buying in - FierceBiotech

The U.K. is open for biotech business, and Merck is buying in - FierceBiotech | Biotech, Pharmas and ideas | Scoop.it
The U.K. is striving to brand itself as a hotbed for biotech R&D, promising new funds for startups, pledging to speed up its approval process and courting some major players to deepen their roots in the country.
more...
No comment yet.
Scooped by Herve Ansanay
Scoop.it!

Hépatite C : "le prix du Sovaldi négocié par le gouvernement est décevant"

Hépatite C : "le prix du Sovaldi négocié par le gouvernement est décevant" | Biotech, Pharmas and ideas | Scoop.it
Le gouvernement a obtenu une baisse du prix de ce médicament, jugé initialement exorbitant. Une négociation loin d'être satisfaisante, selon Jean-François Corty, directeur Mission France de Médecins du monde.
more...
No comment yet.
Scooped by Herve Ansanay
Scoop.it!

BioNano Genomics – a gene mapping startup focused on individual structural variations – gets $53M

BioNano Genomics – a gene mapping startup focused on individual structural variations – gets $53M | Biotech, Pharmas and ideas | Scoop.it
In this era of personalized medicine, individualized gene mapping is key – which is why San Diego startup BioNano Genomics’ Irys System just attracted a robust infusion of cash.
more...
No comment yet.